Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Portal hypertensive gastropathy is associated with iron deficiency anemia.

Simbrunner B, Beer A, Wöran K, Schmitz F, Primas C, Wewalka M, Pinter M, Dolak W, Scheiner B, Puespoek A, Trauner M, Oberhuber G, Mandorfer M, Reiberger T.

Wien Klin Wochenschr. 2020 Jan;132(1-2):1-11. doi: 10.1007/s00508-019-01593-w. Epub 2020 Jan 7.

PMID:
31912289
2.

The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.

Gruber ES, Oberhuber G, Birner P, Schlederer M, Kenn M, Schreiner W, Jomrich G, Schoppmann SF, Gnant M, Tse W, Kenner L.

Cells. 2019 Oct 30;8(11). pii: E1357. doi: 10.3390/cells8111357.

3.

Acute liver failure in immunocompetent patients infected with hepatitis E.

Wenter C, Borena W, Oberhuber G, Graziadei I.

Wien Klin Wochenschr. 2019 Sep;131(17-18):442-445. doi: 10.1007/s00508-019-01547-2. Epub 2019 Sep 6.

4.

Stereotactic Radiofrequency Ablation of Hepatocellular Carcinoma: a Histopathological Study in Explanted Livers.

Bale R, Schullian P, Eberle G, Putzer D, Zoller H, Schneeberger S, Manzl C, Moser P, Oberhuber G.

Hepatology. 2019 Sep;70(3):840-850. doi: 10.1002/hep.30406. Epub 2019 Feb 14.

5.

Iron deficiency workup reveals high incidence of autoimmune gastritis with parietal cell antibody as reliable screening test.

Kulnigg-Dabsch S, Resch M, Oberhuber G, Klinglmueller F, Gasche A, Gasche C.

Semin Hematol. 2018 Oct;55(4):256-261. doi: 10.1053/j.seminhematol.2018.07.003. Epub 2018 Aug 7.

PMID:
30502855
6.

The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.

Schwabl P, Brusilovskaya K, Supper P, Bauer D, Königshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T.

Sci Rep. 2018 Jun 19;8(1):9372. doi: 10.1038/s41598-018-27656-y.

7.

Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma.

Rohr-Udilova N, Klinglmüller F, Schulte-Hermann R, Stift J, Herac M, Salzmann M, Finotello F, Timelthaler G, Oberhuber G, Pinter M, Reiberger T, Jensen-Jarolim E, Eferl R, Trauner M.

Sci Rep. 2018 Apr 18;8(1):6220. doi: 10.1038/s41598-018-24437-5.

8.

ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.

Schmidt S, Schumacher N, Schwarz J, Tangermann S, Kenner L, Schlederer M, Sibilia M, Linder M, Altendorf-Hofmann A, Knösel T, Gruber ES, Oberhuber G, Bolik J, Rehman A, Sinha A, Lokau J, Arnold P, Cabron AS, Zunke F, Becker-Pauly C, Preaudet A, Nguyen P, Huynh J, Afshar-Sterle S, Chand AL, Westermann J, Dempsey PJ, Garbers C, Schmidt-Arras D, Rosenstiel P, Putoczki T, Ernst M, Rose-John S.

J Exp Med. 2018 Apr 2;215(4):1205-1225. doi: 10.1084/jem.20171696. Epub 2018 Feb 22.

9.

Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-Associated Neoplasia.

Frick A, Khare V, Paul G, Lang M, Ferk F, Knasmüller S, Beer A, Oberhuber G, Gasche C.

Mol Cancer Res. 2018 Apr;16(4):634-642. doi: 10.1158/1541-7786.MCR-17-0451. Epub 2018 Jan 29.

10.

Intraductal tubulopapillary neoplasm (ITPN) of the pancreas associated with an invasive component: a case report with review of the literature.

Kuscher S, Steinle H, Soleiman A, Öfner D, Schneeberger S, Oberhuber G.

World J Surg Oncol. 2017 Nov 16;15(1):203. doi: 10.1186/s12957-017-1267-4. Review.

11.

Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) - a rare recently described gastric polyposis syndrome - report of a case.

Beer A, Streubel B, Asari R, Dejaco C, Oberhuber G.

Z Gastroenterol. 2017 Nov;55(11):1131-1134. doi: 10.1055/s-0043-117182. Epub 2017 Nov 15.

PMID:
29141268
12.

ROC-king onwards: intraepithelial lymphocyte counts, distribution and role in coeliac disease mucosal interpretation.

Oberhuber G, Moschen A, Entenmann A, Vogelsang H.

Gut. 2018 Nov;67(11):2069. doi: 10.1136/gutjnl-2017-315403. Epub 2017 Oct 21. No abstract available.

PMID:
29055910
13.

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.

Schwabl P, Hambruch E, Seeland BA, Hayden H, Wagner M, Garnys L, Strobel B, Schubert TL, Riedl F, Mitteregger D, Burnet M, Starlinger P, Oberhuber G, Deuschle U, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Reiberger T, Kremoser C, Trauner M.

J Hepatol. 2017 Apr;66(4):724-733. doi: 10.1016/j.jhep.2016.12.005. Epub 2016 Dec 18.

14.

Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease.

Schwabl P, Mandorfer M, Steiner S, Scheiner B, Chromy D, Herac M, Bucsics T, Hayden H, Grabmeier-Pfistershammer K, Ferlitsch A, Oberhuber G, Trauner M, Peck-Radosavljevic M, Reiberger T.

Aliment Pharmacol Ther. 2017 Jan;45(1):139-149. doi: 10.1111/apt.13844. Epub 2016 Nov 7.

15.

Clinical and Immunologic Features of Ultra-Short Celiac Disease.

Oberhuber G, Vogelsang H.

Gastroenterology. 2016 Oct;151(4):773. doi: 10.1053/j.gastro.2016.06.053. Epub 2016 Aug 30. No abstract available.

PMID:
27590688
16.

Demonstration of Trophozoites of G. Lamblia in Ileal Mucosal Biopsy Specimens May Reveal Giardiasis in Patients With Significantly Inflamed Parasite-free Duodenal Mucosa.

Oberhuber G, Mesteri I, Kopf W, Müller H.

Am J Surg Pathol. 2016 Sep;40(9):1280-5. doi: 10.1097/PAS.0000000000000665.

PMID:
27186850
17.

Reply to: Mucosal histopathology in celiac disease: a rebuttal of Oberhuber´s subdivision of Marsh III.

Oberhuber G, Vogelsang H.

Gastroenterol Hepatol Bed Bench. 2015 Fall;8(4):302. No abstract available.

18.

Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling.

Lang M, Borgmann M, Oberhuber G, Evstatiev R, Jimenez K, Dammann KW, Jambrich M, Khare V, Campregher C, Ristl R, Gasche C.

Mol Cancer. 2013 May 13;12(1):41. doi: 10.1186/1476-4598-12-41.

19.

Cancer prevention in ulcerative colitis: long-term outcome following fluorescence-guided colonoscopy.

Fusco V, Ebert B, Weber-Eibel J, Jost C, Fleige B, Stolte M, Oberhuber G, Rinneberg H, Lochs H, Ortner M.

Inflamm Bowel Dis. 2012 Mar;18(3):489-95. doi: 10.1002/ibd.21703. Epub 2011 Jun 6.

PMID:
21648021
20.

Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis.

Ortner MA, Fusco V, Ebert B, Sukowski U, Weber-Eibel J, Fleige B, Stolte M, Oberhuber G, Rinneberg H, Lochs H.

Gastrointest Endosc. 2010 Feb;71(2):312-8. doi: 10.1016/j.gie.2009.09.029. Epub 2009 Dec 8.

PMID:
20003972
21.

Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis.

Dejaco C, Oesterreicher C, Angelberger S, Püspök A, Birner P, Poetzi R, Gangl A, Oberhuber G.

Endoscopy. 2003 Dec;35(12):1004-8.

PMID:
14648411
22.

An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease.

Dejaco C, Lichtenberger C, Miehsler W, Oberhuber G, Herbst F, Vogelsang H, Gangl A, Reinisch W.

Digestion. 2003;68(2-3):63-70. Epub 2003 Oct 24.

PMID:
14581762
23.

Usefulness of magnetic resonance imaging of cardiac and paracardiac masses.

Hoffmann U, Globits S, Schima W, Loewe C, Puig S, Oberhuber G, Frank H.

Am J Cardiol. 2003 Oct 1;92(7):890-5.

PMID:
14516903
24.

Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes.

Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ambros PF, Ambros IM, Bredel M, Oberhuber G, Rössler K, Budka H, Harris AL, Hainfellner JA.

Brain Pathol. 2003 Apr;13(2):133-43.

PMID:
12744467
25.

Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease.

Geleff S, Schoppmann SF, Oberhuber G.

Virchows Arch. 2003 Mar;442(3):231-7. Epub 2003 Jan 16.

PMID:
12647212
26.

[Histopathological diagnosis of Barrett's mucosa and associated neoplasias. Results of a consensus conference of the Working Group for "Gastroenterological Pathology of the German Society for Pathology" on 22 September 2001].

Faller G, Berndt R, Borchard F, Ell C, Fuchs KH, Geddert H, Gossner L, Günther T, Kirchner T, Koch HK, Langner C, Lüttges J, May A, Müller S, Oberhuber G, Seitz G, Stolte M, Tannapfel A, Vieth M, Walch A, Rüschoff J; Working Group for Gastroenterological Pathology, German Society for Pathology.

Pathologe. 2003 Feb;24(1):9-14. Epub 2003 Jan 15. German.

PMID:
12601473
27.

In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice.

Sturlan S, Beinhauer BG, Oberhuber G, Huang L, Aasen AO, Rogy MA.

Anticancer Res. 2002 Sep-Oct;22(5):2547-54.

PMID:
12529962
28.

Time gated fluorescence spectroscopy in Barrett's oesophagus.

Ortner MA, Ebert B, Hein E, Zumbusch K, Nolte D, Sukowski U, Weber-Eibel J, Fleige B, Dietel M, Stolte M, Oberhuber G, Porschen R, Klump B, Hörtnagl H, Lochs H, Rinneberg H.

Gut. 2003 Jan;52(1):28-33.

29.

Is fluorescence in situ hybridization really superior to HercepTest?

Birner P, Oberhuber G.

J Clin Oncol. 2002 Dec 1;20(23):4607; author reply 4607-9. No abstract available.

PMID:
12454125
30.

Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma.

Reinisch W, Holub M, Katz A, Herneth A, Lichtenberger C, Schoniger-Hekele M, Waldhoer T, Oberhuber G, Ferenci P, Gangl A, Mueller C.

J Immunother. 2002 Nov-Dec;25(6):489-99.

PMID:
12439346
31.

Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography.

Hoffmann M, Oberhuber G, Kletter K, Becherer A, Raderer M.

Clin Nucl Med. 2002 Oct;27(10):731-2. No abstract available.

PMID:
12352119
32.

Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer.

Wenzel C, Locker GJ, Pluschnig U, Zielinski CC, Rudas M, Oberhuber G, Gnant MF, Taucher S, Jakesz R, Steger GG.

Cancer Chemother Pharmacol. 2002 Aug;50(2):155-9. Epub 2002 Jun 7.

PMID:
12172982
33.

Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2002 Jun;8(6):1831-7.

34.

The value of serologic markers in indeterminate colitis: a prospective follow-up study.

Joossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, Geboes K, Bossuyt X, Vandewalle P, Oberhuber G, Vogelsang H, Rutgeerts P, Colombel JF.

Gastroenterology. 2002 May;122(5):1242-7.

PMID:
11984510
35.

The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor alpha decreases the level of galectin-3-specific mRNA in HCT-8 cells.

Jensen-Jarolim E, Gscheidlinger R, Oberhuber G, Neuchrist C, Lucas T, Bises G, Radauer C, Willheim M, Scheiner O, Liu FT, Boltz-Nitulescu G.

Eur J Gastroenterol Hepatol. 2002 Feb;14(2):145-52.

PMID:
11981338
36.

Crohn's disease of the appendix.

Stangl PC, Herbst F, Birner P, Oberhuber G.

Virchows Arch. 2002 Apr;440(4):397-403. Epub 2001 Nov 23.

PMID:
11956821
37.

KAI1 metastasis suppressor protein in cervical cancer.

Schindl M, Birner P, Bachtiary B, Breitenecker G, Selzer E, Oberhuber G.

Am J Pathol. 2002 Apr;160(4):1542-3; author reply 1543. No abstract available.

38.

Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).

Miehlke S, Kirsch C, Dragosics B, Gschwantler M, Oberhuber G, Antos D, Dite P, Läuter J, Labenz J, Leodolter A, Malfertheiner P, Neubauer A, Ehninger G, Stolte M, Bayerdörffer E.

World J Gastroenterol. 2001 Apr;7(2):243-7.

39.

Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries.

Jensen-Jarolim E, Neumann C, Oberhuber G, Gscheidlinger R, Neuchrist C, Reinisch W, Zuberi RI, Penner E, Liu FT, Boltz-Nitulescu G.

J Clin Immunol. 2001 Sep;21(5):348-56.

PMID:
11720007
40.

Prognostic relevance of three histological grading methods in breast cancer.

Latinovic L, Heinze G, Birner P, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Gnant M, Jakesz R, Oberhuber G; Austrian Breast and Colorectal Cancer Study Group.

Int J Oncol. 2001 Dec;19(6):1271-7.

PMID:
11713599
41.

Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.

Schindl M, Birner P, Breitenecker G, Oberhuber G.

Gynecol Oncol. 2001 Nov;83(2):244-8.

PMID:
11606078
42.

Malignancy in slow motion: diagnosis of biochemically apparent, but otherwise occult persistent disease 21 years after resection of a carcinoid tumour of the terminal ileum.

Fiebiger W, Penz M, Längle F, Kurtaran A, Oberhuber G, Raderer M.

Scand J Gastroenterol. 2001 Oct;36(10):1116-8.

PMID:
11589388
43.

DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.

Schindl M, Oberhuber G, Pichlbauer EG, Obermair A, Birner P, Kelley MR.

Int J Oncol. 2001 Oct;19(4):799-802.

PMID:
11562758
44.

In vivo and in vitro permeability in coeliac disease.

Vogelsang H, Schwarzenhofer M, Steiner B, Wyatt J, Oberhuber G.

Aliment Pharmacol Ther. 2001 Sep;15(9):1417-25.

45.

Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer.

Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P.

Cancer Res. 2001 Aug 1;61(15):5703-6.

46.

Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions.

Birner P, Bachtiary B, Dreier B, Schindl M, Joura EA, Breitenecker G, Oberhuber G.

Mod Pathol. 2001 Jul;14(7):702-9.

47.

Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

Birner P, Gatterbauer B, Oberhuber G, Schindl M, Rössler K, Prodinger A, Budka H, Hainfellner JA.

Cancer. 2001 Jul 1;92(1):165-71.

PMID:
11443623
48.

Peripancreatic fat necrosis mimicking pancreatic cancer.

Thurnher MM, Schima W, Turetschek K, Thurnher SA, Függer R, Oberhuber G.

Eur Radiol. 2001;11(6):922-5.

PMID:
11419163
49.

Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.

Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckersberger D, Gnant M, Jakesz R; Austrian Breast & Colorectal Cancer Study Group.

Clin Cancer Res. 2001 Jun;7(6):1669-75.

50.

Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.

Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G.

Clin Cancer Res. 2001 Jun;7(6):1661-8.

Supplemental Content

Loading ...
Support Center